- Confirmed diagnosis of an advanced malignancy in one of two treatment groups: Treatment Group A: any advanced solid tumor (including lymphomas); Treatment Group B: relapsed or refractory AML or high-risk MDS, defined as IPSS INT-2 or greater disease (Maes 1999).